Role of bile acids in the regulation of the metabolic pathways

Identification and Importance of Brown Adipose Tissue in Adult Humans

Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works

Cold-Activated Brown Adipose Tissue in Healthy Men

van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452 · see citing works

Journal of Biological Chemistry

Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,409 · see citing works

The Physiology of Glucagon-like Peptide 1

Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · see citing works

Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human

Wu, J., Boström, P., Sparks, L. M., Li, Y., Choi, J. H., Giang, A.-H., Khandekar, M. J., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,299 · see citing works

Functional Brown Adipose Tissue in Healthy Adults

Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058 · see citing works

Bile salt biotransformations by human intestinal bacteria

Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · see citing works

Identification of a nuclear receptor for bile acids

Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714 · see citing works

PRDM16 controls a brown fat/skeletal muscle switch

Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347 · see citing works

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331 · see citing works

Bile Acids: Natural Ligands for an Orphan Nuclear Receptor

Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · see citing works

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · see citing works

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · see citing works

TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · see citing works

Human gut microbiota in obesity and after gastric bypass

Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880 · see citing works

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · see citing works

Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis

Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · see citing works

A G Protein-coupled Receptor Responsive to Bile Acids

Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · see citing works

PPARs and the complex journey to obesity

Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,621 · see citing works

Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors

Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487 · see citing works

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21025 · Cited by 1,398 · see citing works

Identification of a nuclear receptor that is activated by farnesol metabolites

Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210 · see citing works

Identification of membrane-type receptor for bile acids (M-BAR)

Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993 · see citing works

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 951 · see citing works

FXR is a molecular target for the effects of vertical sleeve gastrectomy

Ryan, K. K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H. E., Sandoval, D. A., Kohli, R., Bäckhed, F., et al. (2014) · Nature · doi:10.1038/nature13135 · Cited by 931 · see citing works

Farnesoid X receptor is essential for normal glucose homeostasis

Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 883 · see citing works

Bile acid biosynthesis

Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819 · see citing works

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1

Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789 · see citing works

6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity

Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743 · see citing works

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738 · see citing works

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705 · see citing works

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesisPreprint

Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 698 · see citing works

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693 · see citing works

TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

Pols, T. W. H., Nomura, M., Harach, T., Sasso, G. L., Oosterveer, M. H., Thomas, C., Rizzo, G., Gioiello, A., Adorini, L., Pellicciari, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.006 · Cited by 622 · see citing works

Endocrine functions of bile acids

Houten, S. M., 渡辺, 光., & Auwerx, J. H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601049 · Cited by 583 · see citing works

Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R. H., Corpuz, R. T., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 580 · see citing works

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576 · see citing works

The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice

Cariou, B., van Harmelen, K., Durán-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 546 · see citing works

Nutrient-sensing nuclear receptors coordinate autophagy

Lee, J. M., Wagner, M., Xiao, R., Kim, K. H., Feng, D., Lazar, M. A., & Moore, D. D. (2014) · Nature · doi:10.1038/nature13961 · Cited by 514 · see citing works

Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region

Hany, T. F., Gharehpapagh, E., Kamel, E. M., Buck, A., Himms-Hagen, J., & von Schulthess, G. K. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0902-6 · Cited by 511 · see citing works

The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice

Wang, Y., Chen, W., Yu, D. D., FORMAN, B. M., & Huang, W. (2011) · Hepatology · doi:10.1002/hep.24525 · Cited by 488 · see citing works

Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor

Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488 · see citing works

Bile Acids Induce the Expression of the Human Peroxisome Proliferator-Activated Receptor α Gene via Activation of the Farnesoid X Receptor

Pineda‐Torra, I., Claudel, T., Duval, C., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0120 · Cited by 485 · see citing works

The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472 · see citing works

The Intraluminal Phase of Fat Digestion in Man: The Lipid Content of the Micellar and Oil Phases of Intestinal Content Obtained during Fat Digestion and Absorption*

Hofmann, A. F., & Borgström, B. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104909 · Cited by 444 · see citing works

Transcriptional regulation of autophagy by an FXR–CREB axis

Seok, S., Fu, T., Choi, S., Yang, L., Zhu, R., Kumar, S., Sun, X., Yoon, G., KANG, Y. Y., Zhong, W., et al. (2014) · Nature · doi:10.1038/nature13949 · Cited by 428 · see citing works

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI: evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424 · see citing works

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Trabelsi, M.-S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S. I., Perino, A., Brighton, C. A., Sebti, Y., Kluza, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8629 · Cited by 404 · see citing works

Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1

Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 363 · see citing works

Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea

Sato, H., Genet, C., Strehle, A., Thomas, C., Lobstein, A., Wagner, A., Mioskowski, C., Auwerx, J. H., & Saladin, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.130 · Cited by 339 · see citing works

Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids

Kast-Woelbern, H. R., Nguyen, C., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 337 · see citing works

The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells

Keitel, V., Reinehr, R., Gatsios, P., Rupprecht, C., Görg, B., Selbach, O., Häussinger, D., & Kubitz, R. (2007) · Hepatology · doi:10.1002/hep.21458 · Cited by 308 · see citing works

Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies

Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A. F., Saladin, R., Schoonjans, K., Pellicciari, R., & Auwerx, J. H. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015864 · Cited by 302 · see citing works

"USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT.

Cohade, C., Mourtzikos, K. A., & Wahl, R. L. (2003) · PubMed · Cited by 295 · see citing works

Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor

Stayrook, K. R., Bramlett, K. S., Savkur, R. S., FICORILLI, J. V., Cook, T. G., Christe, M. E., Michael, L. F., & Burris, T. P. (2004) · Endocrinology · doi:10.1210/en.2004-0965 · Cited by 288 · see citing works

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

Porez, G., Prawitt, J., Gross, B. S., & Staels, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024794 · Cited by 287 · see citing works

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice

Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 285 · see citing works

Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation

Vassileva, G., Golovko, A., Markowitz, L., Abbondanzo, S. J., Zeng, M., Yang, S., Hoos, L. M., Tetzloff, G. G., Levitan, D. J., Murgolo, N., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060537 · Cited by 277 · see citing works

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression

Claudel, T., Inoue, Y., Barbier, O., Durán-Sandoval, D., Kosykh, V., Fruchart, J., Fruchart, J., Gonzalez, F. J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00896-5 · Cited by 269 · see citing works

The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling

Li, T., Holmstrom, S. R., Kır, S., Umetani, M., Schmidt, D. R., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0460 · Cited by 267 · see citing works

Discovery of 6α-Ethyl-23( S )-methylcholic Acid ( S -EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity

Pellicciari, R., Gioiello, A., Macchiarulo, A., Thomas, C., Rosatelli, E., Natalini, B., Sardella, R., Pruzanski, M., Roda, A., Pastorini, E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901390p · Cited by 263 · see citing works

Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal

Abu-Elheiga, L. A., Matzuk, M. M., Kordari, P., Oh, W. K., Shaiken, T. E., Gu, Z., & Wakil, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505714102 · Cited by 263 · see citing works

Glucose Regulates the Expression of the Farnesoid X Receptor in Liver

Durán-Sandoval, D., Mautino, G., Martin, G., Percevault, F., Barbier, O., Fruchart, J., Kuipers, F., & Staels, B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.890 · Cited by 258 · see citing works

Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure

渡辺, 光., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 255 · see citing works

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

Fonseca, V. A., Rosenstock, J., Wang, A. C., Truitt, K. E., & Jones, M. R. (2008) · Diabetes Care · doi:10.2337/dc08-0283 · Cited by 243 · see citing works

The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression

Urizar, N. L., Dowhan, D. H., & Moore, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007998200 · Cited by 238 · see citing works

Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

Zieve, F. J., Kalin, M. F., Schwartz, S. L., Jones, M. R., & Bailey, W. L. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.01.003 · Cited by 216 · see citing works

Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Bays, H. E., Goldberg, R. B., Truitt, K. E., & Jones, M. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.1975 · Cited by 212 · see citing works

Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice

Qi, Y., Jiang, C., Cheng, J., Krausz, K. W., Li, T., Ferrell, J. M., Gonzalez, F. J., & Chiang, J. Y. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.04.008 · Cited by 205 · see citing works

The Small Heterodimer Partner Interacts with the Liver X Receptor α and Represses Its Transcriptional Activity

Brendel, C., Schoonjans, K., Botrugno, O. A., Treuter, E., & Auwerx, J. H. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0194 · Cited by 199 · see citing works

Protective Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in Estrogen-Induced Cholestasis

Fiorucci, S., Clerici, C., Antonelli, E., Orlandi, S., Goodwin, B. J., Sadeghpour, B. M., Sabatino, G., Russo, G., Castellani, D., Willson, T. M., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079665 · Cited by 196 · see citing works

Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy

Goldberg, R. B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1531 · Cited by 194 · see citing works

Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery

Nakatani, H., Kasama, K., Oshiro, T., Watanabe, M., Hirose, H., & Itoh, H. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.006 · Cited by 192 · see citing works

Bile Acid Reduces the Secretion of Very Low Density Lipoprotein by Repressing Microsomal Triglyceride Transfer Protein Gene Expression Mediated by Hepatocyte Nuclear Factor-4

Hirokane, H., Nakahara, M., Tachibana, S., Shimizu, M., & Sato, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404255200 · Cited by 189 · see citing works

Cholestyramine Therapy for Dyslipidemia in Non–Insulin-dependent Diabetes Mellitus: A Short-Term, Double-Blind, Crossover Trial

Garg, A., & Grundy, S. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-6-199409150-00004 · Cited by 187 · see citing works

Lipoic acid entrains the hepatic circadian clock and lipid metabolic proteins that have been desynchronized with advanced age

Keith, D. J., Finlay, L. A., Butler, J. A., Gómez, L. A., Smith, E., Moreau, R. F., & Hagen, T. M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.112 · Cited by 184 · see citing works

Bile acids induce monocyte differentiation toward interleukin‐12 hypo‐producing dendritic cells via a TGR5‐dependent pathway

Ichikawa, R., Takayama, T., Yoneno∥, K., Kamada, N., Kitazume, M. T., Higuchi, H., Matsuoka, K., 渡辺, 光., Itoh, H., Kanai∥, T., et al. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03554.x · Cited by 163 · see citing works

Alternate pathways of bile acid synthesis in the cholesterol 7α-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding

Schwarz, M., Russell, D. W., Dietschy, J. M., & Turley, S. D. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32213-6 · Cited by 155 · see citing works

Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism

Thomas, C., Auwerx, J. H., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 154 · see citing works

Vitamin D and energy homeostasis—of mice and men

Bouillon, R., Carmeliet, G., Lieben, L., 渡辺, 光., Perino, A., Auwerx, J. H., Schoonjans, K., & Verstuyf, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.226 · Cited by 146 · see citing works

Brown Adipose Tissue as a Regulator of Energy Expenditure and Body Fat in Humans

Saito, M. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.22 · Cited by 146 · see citing works

Angiopoietin-like Protein 3 Mediates Hypertriglyceridemia Induced by the Liver X Receptor

Inaba, T., Matsuda, M., Shimamura, M., Takei, N., Terasaka, N., Ando, Y., Yasumo, H., Koishi, R., Makishima, M., & Shimomura, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213202200 · Cited by 138 · see citing works

A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes

Han, S., Li, T., Ellis, E. C. S., Strom, S. C., & Chiang, J. Y. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0482 · Cited by 137 · see citing works

Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form.

PRESTA, M., RUSNATI, M., Maier, J. A., et al. (1988) · Institutional Research Information System (Università degli Studi di Brescia) · doi:10.1016/s0006-291x · Cited by 120 · see citing works

Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia

Zhang, Y., Yin, L., Anderson, J., Ma, H., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083899 · Cited by 112 · see citing works

Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure

渡辺, 光., Morimoto, K., Houten, S. M., Kaneko-Iwasaki, N., Sugizaki, T., Horai, Y., Mataki, C., Sato, H., Murahashi, K., Arita, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038286 · Cited by 112 · see citing works

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1

Shang, Q., Saumoy, M., Holst, J. J., Salen, G., & Xu, G. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2009 · Cited by 110 · see citing works

The farnesoid X receptor induces very low density lipoprotein receptor gene expression

Sirvent, A., Claudel, T., Martin, G., Brozek, J., Kosykh, V., Darteil, R., Hum, D. W., Fruchart, J., & Staels, B. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.026 · Cited by 109 · see citing works

Nuclear 3,5,3′-Triiodothyronine (T3) in Brown Adipose Tissue: Receptor Occupancy and Sources of T3as Determined byin VivoTechniques*

Bianco, A. C., & Silva, J. E. (1987) · Endocrinology · doi:10.1210/endo-120-1-55 · Cited by 102 · see citing works

Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor

Savkur, R. S., Bramlett, K. S., Michael, L. F., & Burris, T. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.141 · Cited by 93 · see citing works

Colestimide Lowers Plasma Glucose Levels and Increases Plasma Glucagon-like Peptide-1 (7-36) Levels in Patients with Type 2 Diabetes Mellitus Complicated by Hypercholesterolemia

Suzuki, T., Oba, K., Igari, Y., Matsumura, N., Watanabe, K., Futami‐Suda, S., Yasuoka, H., Ouchi, M., Suzuki, K., Kigawa, Y., et al. (2007) · Journal of Nippon Medical School · doi:10.1272/jnms.74.338 · Cited by 93 · see citing works

Cholestyramine Reverses Hyperglycemia and Enhances Glucose-Stimulated Glucagon-Like Peptide 1 Release in Zucker Diabetic Fatty Rats

Chen, L., McNulty, J. A., Anderson, D., Liu, Y., Nystrom, C., Bullard, S., Collins, J. L., Handlon, A. L., Klein, R. R., Grimes, A. M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166892 · Cited by 75 · see citing works

Antagonism of the Actions of Peroxisome Proliferator-activated Receptor-α by Bile Acids

Sinal, C. J., Yoon, M., & Gonzalez, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107000200 · Cited by 74 · see citing works

Bile Acids Increase Levels of MicroRNAs 221 and 222, Leading to Degradation of CDX2 During Esophageal Carcinogenesis

Matsuzaki, J., Suzuki, H., Tsugawa, H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.008 · Cited by 71 · see citing works

Untersuchungen zur Gallensteinauflösung in vivo

Fromm, H., Eschler, A., Töllner, D., et al. (1975) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1106432 · Cited by 43 · see citing works

Autophagy transcribed

Settembre, C., & Ballabio, A. (2014) · Nature · doi:10.1038/nature13939 · Cited by 30 · see citing works

Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus

Henry, R. R., Aroda, V. R., Mudaliar, S. R. D., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01486.x · Cited by 28 · see citing works

Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus

Müssig, K., Staiger, H., Machicao, F. E., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.012 · Cited by 27 · see citing works

Bile acid represses the peroxisome proliferator-activated receptor-γ coactivator-1 promoter activity in a small heterodimer partner-dependent manner

Yamagata, K., Yoshimochi, K., Daitoku, H., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.751 · Cited by 20 · see citing works

Serum, fecal and urinary bile acids in patients with mild and advanced liver cirrhosis

Amuro, Y., Endo, T., Higashino, K., et al. (1981) · Gastroenterologia Japonica · doi:10.1007/bf02774522 · Cited by 17 · see citing works

Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver

Tagawa, H., Irie, J., Itoh, A., Kusumoto, Y., Kato, M., Kobayashi, N., Tanaka, K., Morinaga, R., Fujita, M., Nakajima, Y., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.025 · Cited by 12 · see citing works

Bile Salt Hydrolase Activity in the Food-Derived Strain Levilactobacillus brevis M3R3: Genomic and Functional Characterization

Agolino, G., Cristofolini, M., Ronsivalle, M. A., Cattivelli, A., Tagliazucchi, D., Caggia, C., Solieri, L., & Randazzo, C. L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10810-0 · Cited by 1 · see citing works

Bile acid metabolism and signaling in liver disease and therapy

Chiang, J. Y. L. (2017) · Liver Research · doi:10.1016/j.livres.2017.05.001 · Cited by 301 · see citing works

Bile acid metabolism and type 2 diabetes

Niu, S., & Han, Z. (2014) · Intern J Endocrinol Metab · doi:10.3760/cma.j.issn.1673-4157.2014.03.013

Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes

Prawitt, J., Caron, S., & Staels, B. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0187-x · Cited by 239 · see citing works

The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance

Yan, X., Li, P., Tang, Z., et al. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0211-5 · Cited by 8 · see citing works

Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases

Malhi, H., & Camilleri, M. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.09.008 · Cited by 54 · see citing works